日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Crizotinib in Patients with Tumors with MET Amplification or Exon 14 Deletion: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols C1 and C2

克唑替尼治疗MET扩增或14号外显子缺失的肿瘤患者:NCI-MATCH ECOG-ACRIN试验(EAY131)C1和C2子方案的结果

Coleman, Niamh; Wei, Zihan; Iafrate, A John; Zwiebel, James A; Sharon, Elad; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Takebe, Naoko; Williams, Travis; Croley, Jessica J; Onitilo, Adedayo A; Tricoli, James V; Cheng, Ju; Karlovich, Chris; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay; O'Dwyer, Peter J; Hong, David S; Chen, Alice P; Flaherty, Keith T

Phase II Study of Dabrafenib and Trametinib in Patients With Tumors With BRAF(V600E) Mutations: Updated Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol H

达拉非尼和曲美替尼治疗BRAF(V600E)突变肿瘤患者的II期研究:NCI-MATCH ECOG-ACRIN试验(EAY131)子方案H的最新结果

Salama, April K S; Wang, Victoria; Macrae, Erin R; Park, Jong-In; Chen, Helen X; Gray, Robert J; McShane, Lisa M; Rubinstein, Larry V; Patton, David; Williams, P Mickey; Hamilton, Stanley R; Armstrong, Deborah K; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E

拉罗替尼治疗NTRK融合肿瘤患者:NCI-MATCH ECOG-ACRIN试验(EAY131)子方案EAY131-Z1E的结果

Akhave, Neal; Song, Zihe; Hong, David S; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Takebe, Naoko; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

On the Unfairness of the 'Fair-share Principle' for Health Research

论“公平份额原则”在健康研究中的不公平性

Wang, Victoria Min-Yi

Epigenome-Wide Analysis Identifies Pollution-Sensitive Loci in Fibrotic Interstitial Lung Disease

全基因组表观遗传分析鉴定出纤维化间质性肺病中的污染敏感基因位点

Goobie, Gillian C; Assadinia, Najmeh; Yang, Chen Xi; Chu, Fanny; Clifford, Rachel L; Cooper, Joel D; Fabisiak, James P; Gibson, Kevin F; Johannson, Kerri A; Kass, Daniel J; Kim, Sharon E; Li, Xiaoyun; Lindell, Kathleen O; Marinescu, Daniel-Costin; Vasilescu, Dragos M; Wang, Victoria; Carlsten, Christopher; Nouraie, S Mehdi; Ryerson, Christopher J; Hackett, Tillie L; Zhang, Yingze

Controlling nephron precursor differentiation to generate proximal-biased kidney organoids with emerging maturity.

控制肾单位前体分化,生成具有逐渐成熟的近端偏向肾脏类器官

Schnell Jack, Miao Zhen, Achieng MaryAnne, Fausto Connor C, Koppitch Kari, Takhirov Lola, Wang Victoria, De Kuyper Faith, Huang Biao, Schreiber Megan, Medina Pedro, Thornton Matthew E, Grubbs Brendan, Li Zhongwei, Kim Junhyong, Lindström Nils O

Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D

基于下一代测序的MSI评分可预测错配修复缺陷型肿瘤患者接受纳武利尤单抗治疗的获益:NCI-MATCH Z1D组随访研究

Schoenfeld, Jonathan D; Azad, Nilofer S; Gross, Jacob; Chen, Li; Overman, Michael J; Kao, Katrina; Jackson, Latifa; Brunnquell, Donna; Bu, Xiangning; Coppola, Christina; Guan, Ping; Lee, Jennifer; Sims, David; Fuchs, Rebecca; Weirather, Jason L; Pfaff, Kathleen L; Gunasti, Lauren; Ranasinghe, Srin; Hamilton, Stanley R; Wang, Victoria; O'Dwyer, Peter J; Wu, Catherine J; Rodig, Scott J; Patton, David R; Harris, Lyndsay

Phase II Study of Palbociclib in Patients with Tumors with CDK4 or CDK6 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1C

帕博西尼治疗 CDK4 或 CDK6 扩增肿瘤患者的 II 期研究:NCI-MATCH ECOG-ACRIN 试验 (EAY131) 子方案 Z1C 的结果

O'Hara, Mark H; Jegede, Opeyemi; Dickson, Mark A; DeMichele, Angela M; Piekarz, Richard; Gray, Robert J; Wang, Victoria; McShane, Lisa M; Rubinstein, Lawrence V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Onitilo, Adedayo; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos L; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1K

伊帕他塞替治疗AKT突变肿瘤患者:NCI-MATCH ECOG-ACRIN试验(EAY131)子方案Z1K的结果

McCourt, Carolyn K; Wei, Zihan; Kalinsky, Kevin; Gray, Robert; Wang, Victoria; McShane, Lisa M; Rubinstein, Larry V; Patton, David R; Williams, P Mickey; Hamilton, Stanley R; Force, Jeremy; Pakanati, Anuradha; Tricoli, James V; Conley, Barbara A; Arteaga, Carlos; Harris, Lyndsay N; O'Dwyer, Peter J; Chen, Alice P; Flaherty, Keith T

Damage sensing through TLR9 regulates inflammatory and antiviral responses during influenza infection

TLR9介导的损伤感知调节流感感染期间的炎症和抗病毒反应

Kim, Jooyoung; Yuan, Yifan; Agaronyan, Karen; Zhao, Amy; Wang, Victoria D; Gau, David; Toosi, Nicholas; Gupta, Gayatri; Essayas, Heran; Kaminski, Ayelet; McGovern, John; Yu, Sheeline; Woo, Samuel; Lee, Chris J; Gandhi, Shifa; Saber, Tina; Saleh, Tayebeh; Hu, Buqu; Sun, Ying; Ishikawa, Genta; Bain, William; Evankovich, John; Chen, Lujia; Yun, HongDuck; Herzog, Erica L; Dela Cruz, Charles S; Ryu, Changwan; Sharma, Lokesh